Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
1,273 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02445248 | Study of Efficacy and Safety of CTL019 in Adult DLBCL Patients(JULIET) | completed | Phase 2 | 115 | Novartis PharmaceuticalsINDUSTRY | 10 | Apr 18, 2024 | clinicaltrials |
| NCT01246739 | Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome(AUSC) | terminated | N/A | 34 | Region SkaneOTHER | 3 | Apr 10, 2024 | clinicaltrials |
| NCT02240836 | Energy Balance and Breast Cancer Aspects-II(EBBA-II) | active not recruiting | N/A | 545 | Oslo University HospitalOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT05130099 | A Complex Intervention for Chronically Fatigued Lymphoma Survivors | unknown | N/A | 150 | Oslo University HospitalOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT05736094 | Ultrasound for Detection of Prostate Cancer(SURF) | completed | N/A | 11 | Oslo University HospitalOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT03548571 | Dendritic Cell Immunotherapy Against Cancer Stem Cells in Glioblastoma Patients Receiving Standard Therapy(DEN-STEM) | unknown | Phase 2 / Phase 3 | 60 | Oslo University HospitalOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT04672265 | Increasing Access to Breast Cancer Screening Among Immigrants | active not recruiting | N/A | 11,355 | Oslo University HospitalOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT05043701 | Individualized Systems Medicine Functional Profiling for Recurrent Glioblastoma(ISM-GBM) | unknown | Early Phase 1 | 15 | Oslo University HospitalOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT05186493 | Laparoscopic Robot-assisted Pelvic Exenteration for Pelvic Primary and Recurrent Cancers | recruiting | N/A | 40 | Oslo University HospitalOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT05447273 | The Role of Functional Magnetic Resonance Imaging in Preoperative Assessment of Primary Penile Carcinoma | recruiting | — | 60 | Oslo University HospitalOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT06205290 | A Study to Compare the Efficacy and Safety of Lisocabtagene Maraleucel vs Investigator's Choice Options in Adult Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, Whose Disease Has Failed Treatment With Both BTKi and BCL2i Therapies | withdrawn | Phase 3 | 0 | Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyINDUSTRY | 11 | Apr 2, 2024 | clinicaltrials |
| NCT02603432 | A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) | completed | Phase 3 | 700 | PfizerINDUSTRY | 29 | Mar 27, 2024 | clinicaltrials |
| NCT06270667 | Effects of Exercise Training in Survivors of Lymphoma(LYMfit) | recruiting | N/A | 280 | Norwegian School of Sport SciencesOTHER | 2 | Mar 22, 2024 | clinicaltrials |
| NCT02414139 | Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1) | completed | Phase 2 | 373 | Novartis PharmaceuticalsINDUSTRY | 20 | Mar 20, 2024 | clinicaltrials |
| NCT05883800 | Total Neoadjuvant Treatment Combined With Adaptive Radiotherapy for Rectal Cancer(TNT-RECORD) | recruiting | N/A | 61 | Haukeland University HospitalOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT03267030 | Asparaginase Encapsulated in Erythrocytes for Patients With ALL and Hypersensitivity to PEG-asparaginase | completed | Phase 2 | 55 | Birgitte Klug AlbertsenOTHER | 6 | Mar 15, 2024 | clinicaltrials |
| NCT02451111 | Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma | terminated | Phase 2 | 190 | Swiss Cancer InstituteOTHER | 6 | Mar 13, 2024 | clinicaltrials |
| NCT03246412 | Nevus Doctor Clinical Decision Support for GPs | completed | N/A | 35 | University Hospital of North NorwayOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT00330447 | Effects of Oncological Treatment During Pregnancy on Mother and Child | recruiting | — | 5,000 | University Hospital, GasthuisbergOTHER | 20 | Mar 6, 2024 | clinicaltrials |
| NCT02278900 | Supporting Doctor-patient Communication in Oncology | terminated | N/A | 180 | University Hospital of North NorwayOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT00895388 | Effects of Structured Rehabilitation Program on Quality of Life in Rectal Cancer Patients- a Randomized Controlled Trial | withdrawn | N/A | 0 | University Hospital of North NorwayOTHER | 1 | Mar 5, 2024 | clinicaltrials |
| NCT02759679 | Canine-Assisted Profiling of Lung Cancer From Human Breath | terminated | N/A | 650 | Haukeland University HospitalOTHER | 1 | Mar 1, 2024 | clinicaltrials |
| NCT01588262 | Early Rehabilitation of Cancer Patients | completed | N/A | 300 | Haukeland University HospitalOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT04300244 | Nivolumab and Ipilimumab +/- UV1 Vaccination as Second Line Treatment in Patients With Malignant Mesothelioma(NIPU) | active not recruiting | Phase 2 | 118 | Åslaug HellandOTHER | 5 | Feb 29, 2024 | clinicaltrials |
| NCT04392505 | Durvalumab(MEDI4736) After chemoRadioTherapy(DART) for NSCLC-a Translational and Biomarker Study(DART) | active not recruiting | Phase 2 | 100 | Oslo University HospitalOTHER | 4 | Feb 29, 2024 | clinicaltrials |
| NCT04817956 | Improving Public Cancer Care by Implementing Precision Medicine in Norway(IMPRESS-N) | recruiting | Phase 2 | 3,000 | Oslo University HospitalOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT04245943 | Rehabilitation - Physical Activity and Coping(RPAC) | unknown | N/A | 20 | Haukeland University HospitalOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT06057350 | Surgery Versus Endoscopic Resection for Incompletely Removed Early Colon CAnceR(SCAR) | recruiting | N/A | 304 | Norwegian Department of Health and Social AffairsOTHER_GOV | 2 | Feb 16, 2024 | clinicaltrials |
| NCT02435849 | Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients(ELIANA) | completed | Phase 2 | 80 | Novartis PharmaceuticalsINDUSTRY | 11 | Feb 13, 2024 | clinicaltrials |
| NCT05214183 | Acalabrutinib and Rituximab in Elderly Patients With Untreated Mantle Cell Lymphoma(ALTAMIRA) | active not recruiting | Phase 2 | 81 | Nordic Lymphoma GroupNETWORK | 5 | Feb 12, 2024 | clinicaltrials |
| NCT01802814 | International Study for Treatment of Standard Risk Childhood Relapsed ALL 2010 | completed | Phase 3 | 700 | Charite University, Berlin, GermanyOTHER | 17 | Feb 9, 2024 | clinicaltrials |
| NCT01479608 | Liver Transplantation and Colorectal Cancer | recruiting | N/A | 25 | Oslo University HospitalOTHER | 1 | Feb 7, 2024 | clinicaltrials |
| NCT03834220 | Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial) | terminated | Phase 2 | 63 | Debiopharm International SAINDUSTRY | 23 | Feb 7, 2024 | clinicaltrials |
| NCT02215889 | Partial Liver Segment 2/3 Transplantation Study | recruiting | Phase 1 / Phase 2 | 20 | Oslo University HospitalOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT03494946 | Liver Transplantation Compared to Chemotherapy in Patients With ColoRectal Cancer(SECAIII) | recruiting | N/A | 30 | Oslo University HospitalOTHER | 1 | Feb 6, 2024 | clinicaltrials |
| NCT02478502 | Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer | terminated | Phase 2 | 14 | University Hospital, AkershusOTHER | 4 | Feb 2, 2024 | clinicaltrials |
| NCT02149849 | Surgical Positioning of the Arm During Thoracic Surgery -Effect on Shoulder Pain After Surgery? | completed | N/A | 30 | Oslo University HospitalOTHER | 1 | Jan 30, 2024 | clinicaltrials |
| NCT03151811 | A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide(OCEAN) | terminated | Phase 3 | 495 | Oncopeptides ABINDUSTRY | 21 | Jan 30, 2024 | clinicaltrials |
| NCT04785547 | ALL SCTped 2012 FORUM Add-on Study Blina Post HSCT | terminated | Phase 2 | 3 | Prof. Christina PetersOTHER | 10 | Jan 16, 2024 | clinicaltrials |
| NCT02965950 | The p53 Breast Cancer Trial(p53b) | active not recruiting | Phase 2 | 190 | Haukeland University HospitalOTHER | 1 | Jan 12, 2024 | clinicaltrials |
| NCT02745002 | Navigated EBUS and Functional Imaging in Lung Cancer | completed | N/A | 8 | St. Olavs HospitalOTHER | 1 | Jan 10, 2024 | clinicaltrials |
| NCT03188354 | Diagnostic Assessment of 18F-fluciclovine and 18F-FDG -PET/MRI of Primary Central Nervous System Lymphoma | completed | N/A | 3 | Norwegian University of Science and TechnologyOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT03443856 | Postoperative Immunotherapy vs Standard Chemotherapy for Gastric Cancer With High Risk for Recurrence(VESTIGE) | unknown | Phase 2 | 197 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jan 5, 2024 | clinicaltrials |
| NCT04025606 | Paravertebral Block Versus Thoracic Epidural Analgesia | completed | N/A | 94 | St. Olavs HospitalOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT04758026 | H&N Cancer; Survivorship and Late Effects | completed | — | 265 | Oslo University HospitalOTHER | 1 | Jan 3, 2024 | clinicaltrials |
| NCT00218868 | Cytodiagnosis of Basal Cell Carcinoma and Actinic Keratosis Using Papanicolaou and May-grunwald-giemsa Stained Tissue Smear | completed | — | 66 | Norwegian University of Science and TechnologyOTHER | 1 | Dec 29, 2023 | clinicaltrials |
| NCT03806179 | Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL(LYMRIT-37-07) | completed | Phase 1 | 7 | Nordic NanovectorINDUSTRY | 2 | Dec 22, 2023 | clinicaltrials |
| NCT04151563 | A Clinical Study Evaluating Nivolumab-containing Treatments in Patients With Advanced Non-small Cell Lung Cancer After Failing Previous PD-1/(L)1 Therapy and Chemotherapy(CheckMate 79X) | withdrawn | Phase 1 / Phase 2 | 0 | Bristol-Myers SquibbINDUSTRY | 10 | Dec 19, 2023 | clinicaltrials |
Data updated 24 days agoSource updated unknownsource: clinicaltrials